• Explore /
  • Poster
  • / Keynote 290: Pembrolizumab (pem) in combination with stereotactic body radiotherapy for resectable liver metastatic colorectal cancer.

Keynote 290: Pembrolizumab (pem) in combination with stereotactic body radiotherapy for resectable liver metastatic colorectal cancer.

Abstract Poster

Authors

null

Dustin A. Deming

University of Wisconsin Carbone Cancer Center, Madison, WI

Dustin A. Deming , David H. Kim , Kristina Matkowskyj , Nataliya Volodymyrivna Uboha , Sam Joseph Lubner , Noelle K. LoConte , Daniel Mulkerin , Daniel Abbott , Sharon M. Weber , Emily Winslow , Robert Jeraj , Mark A. Ritter , Scott Perlman , Jens C. Eickhoff , Michael Frederick Bassetti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02837263

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS874)

DOI

10.1200/JCO.2018.36.4_suppl.TPS874

Abstract #

TPS874

Poster Bd #

Q2

Abstract Disclosures

Similar Posters

First Author: Anita Ahmed Turk

First Author: Dustin A. Deming

First Author: Austin G. Duffy

First Author: Carlo Guerrero